Aberrant TGF‐β signaling can upregulate the expression of proangiogenic factors such as vascular endothelial growth factor (VEGF), platelet‐derived growth factor (PDGF), and basic fibroblast growth factor (bFGF), resulting in increased blood vessel density and tumor size [18, 19]. This evidence concerns the gene FGF2 and neoplasm.